Measles Maternal Antibodies With Low Avidity Do Not Interfere With the Establishment of Robust Quantity and Quality Antibody Responses After the Primary Dose of Measles, Mumps, and Rubella Vaccine Administered at 12-Months of Age.
J Pediatric Infect Dis Soc
; 9(6): 752-755, 2020 Dec 31.
Article
em En
| MEDLINE
| ID: mdl-31644795
ABSTRACT
In this study, we illustrate, for the first time, that preexisting low-avidity neutralizing measles maternal antibodies do not interfere with the development of high concentrations of high-avidity measles antibodies in children immunized at age 12 months. This suggests that the quality of measles maternal antibodies, rather than the quantity, impacts immunogenicity of primary measles immunization.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Sarampo
/
Caxumba
Limite:
Child
/
Humans
/
Infant
Idioma:
En
Revista:
J Pediatric Infect Dis Soc
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Estados Unidos